Zynerba Pharmaceuticals Statistics Share Statistics Zynerba Pharmaceuticals has 53.94M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 53.94M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 35.45M Failed to Deliver (FTD) Shares 4,201 FTD / Avg. Volume 0.4%
Short Selling Information The latest short interest is 419.98K, so 0% of the outstanding
shares have been sold short.
Short Interest 419.98K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.65 and the forward
PE ratio is null.
Zynerba Pharmaceuticals's PEG ratio is
0.04.
PE Ratio -0.65 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.49 P/FCF Ratio -0.98 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Zynerba Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.97,
with a Debt / Equity ratio of 0.01.
Current Ratio 5.97 Quick Ratio 5.97 Debt / Equity 0.01 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 163.4
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.39M Employee Count 25 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -215.73K Effective Tax Rate 0.62%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.19, so Zynerba Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.19 52-Week Price Change n/a 50-Day Moving Average 1.19 200-Day Moving Average 0.62 Relative Strength Index (RSI) 58.62 Average Volume (20 Days) 1,043,239
Income Statement
Revenue n/a Gross Profit n/a Operating Income -35.25M Net Income -34.82M EBITDA -34.62M EBIT -35.25M Earnings Per Share (EPS) -0.82
Full Income Statement Balance Sheet The company has 50.64M in cash and 334.43K in
debt, giving a net cash position of 50.31M.
Cash & Cash Equivalents 50.64M Total Debt 334.43K Net Cash 50.31M Retained Earnings -274.52M Total Assets 40.48M Working Capital 27.84M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -23.03M
and capital expenditures -154.1K, giving a free cash flow of -23.18M.
Operating Cash Flow -23.03M Capital Expenditures -154.1K Free Cash Flow -23.18M FCF Per Share -0.54
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
